Mandate

Vinge advises EQT VI on acquisition of Atos Medical

July 22, 2011

Vinge is advising funds managed by EQT VI Limited in connection with the acquisition of Atos Medical from funds managed by Nordic Capital V Limited (94.6%) and board directors and employees (5.4%). Atos supplies products to the ear, nose and throat (“ENT”) medical segment and is the market leader in voice prosthesis. The acquisition is subject to customary conditions.

The Vinge team included partners Christina Kokko and Johan Göthberg and associates Malin Helgesen, Peter Sundgren, Paul Dali and Anna-Sofia Nilsson Prevell (M&A), partner Maria-Pia Hope and associates Albert Wållgren and Andreas Malmberg (banking & finance), and partner Marcus Glader and associate Peter Alstergren (EU & competition).

Related

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB

Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB
April 24, 2025

Vinge advises Biotage in connection with RWK Bidco’s public tender

On 22 April 2025, RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, announced a public tender offer to the shareholders in Biotage AB to tender all ordinary shares in Biotage to RWK Bidco at a price of SEK 145 in cash per ordinary share.
April 22, 2025

Vinge advises Baseload Capital in connection with an investment from Google

Vinge has advised Baseload Capital Holding AB in connection with securing an investment from Google.
April 16, 2025